About MODERN CHI MED Company

Modern Chinese Medicine Group Co., Ltd. is one of the pioneers of the modernization of traditional Chinese medicine in China. Our main operating subsidiary, Chengde Yumuro Jindan Pharmaceutical Co., Ltd., is a traditional Chinese medicine pharmaceutical company with a long history. Our development history can be traced back to 1986. Adhering to the corporate mission of “building a national traditional Chinese medicine industry and focusing on the healthy development of traditional Chinese medicine”, we have always focused on the innovation and development of blood supplementation, cardiovascular, digestive, gynecological proprietary Chinese medicines, the coronavirus and/or similar conditions (starting from FY2020). We have 71 drug approval numbers and produce 59 kinds of proprietary Chinese medicine products. Of these, 45 products are included in the “National Medical Insurance Drug Catalogue”. We are a leading manufacturer of proprietary Chinese medicine pills and cardiovascular and cerebrovascular proprietary Chinese medicine capsules in Northeast China. We have major product groups such as Qi and Blood Double Supplement Pills, Shanmei Capsules, Jinqu Kidney Qi Pills, Xin'an Capsules, Flavoured Xiaoyao Pills, Agastache Zhengqi Pills, Qingfeng Detox Pills, and Liver Protection Tablets. Among them, three major products occupy leading positions in the market: kidney supplement pills, qi and blood double supplement pills, and Shanmei capsules. We have implemented a strict quality control system, established a sound enterprise management system and various operating rules, built a first-class management, production and distribution elite team, and achieved standardized enterprise management. We promote enterprise development through research and development, and have signed cooperation agreements with Heilongjiang University of Traditional Chinese Medicine and Chengde Medical College to jointly develop new drugs and enhance our product expertise. The company's main product, Shanmei Capsule, is the original drug. It was issued a new drug certificate by the Chinese Ministry of Health in 1995. It was listed as a second-class protected variety of traditional Chinese medicine by the China Drug Administration. In 2016, it was awarded the title of famous brand product for small and medium-sized enterprises in Hebei Province by the Hebei Provincial Department of Industry and Information Technology. Based on our geography and our own advantages, we are based in Hebei and are deeply involved in the North China and Northeast China markets while vigorously expanding the East China, South China, Southwest China, and Northwest China, gradually building an efficient marketing network covering the whole country. After years of development, we have established a unique brand advantage. “Imperial Room” brand products are highly trusted by customers due to their competitiveness and diversified combinations, and have always enjoyed a reputation in the national pharmaceutical market. Entering the 21st century, the company has formulated a development direction of “grouping-up, intensification, and internationalization”, with the aim of striving to build a first-class domestic and internationally renowned modern traditional Chinese medicine pharmaceutical group.